SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001558370-22-001617
Filing Date
2022-02-22
Accepted
2022-02-22 16:45:46
Documents
15
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-K/A aytu-20210630x10ka.htm   iXBRL 10-K/A 100060
2 EX-31.1 aytu-20210630xex31d1.htm EX-31.1 15260
3 EX-31.2 aytu-20210630xex31d2.htm EX-31.2 14060
4 GRAPHIC aytu-20210630x10ka001.jpg GRAPHIC 2574
  Complete submission text file 0001558370-22-001617.txt   309041

Data Files

Seq Description Document Type Size
5 EX-101.SCH aytu-20210630.xsd EX-101.SCH 2589
6 EX-101.LAB aytu-20210630_lab.xml EX-101.LAB 21921
7 EX-101.PRE aytu-20210630_pre.xml EX-101.PRE 14096
9 EXTRACTED XBRL INSTANCE DOCUMENT aytu-20210630x10ka_htm.xml XML 7430
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K/A | Act: 34 | File No.: 001-38247 | Film No.: 22658903
SIC: 2834 Pharmaceutical Preparations